`Case 1:22-cv-02229-MKV Document5 Filed 03/18/22 Page 1 of 2
`
`TRADEMARK
`
`Mail Stop 8
`Director of the U.S. Patent and Trademark Office
`P.O. Box 1450
`Alexandria, VA 22313-1450
`
`REPORT ON THE
`FILING OR DETERMINATION OF AN
`ACTION REGARDING A PATENT OR
`
`In Compliance with 35 U.S.C. § 290 and/or 15 U.S.C. § 1116 you are hereby advised that a court action has been
`
`filed in the U.S. District Court
`for the Southern District of New York
`on the following
`G
`G
`G
`(Patents.
`(J Trademarksor
`( (1 the patent action involves 35 U.S.C. § 292.):
`DOCKET NO.
`DATEFILED
`3/18/2022
`Formatm/d/yyyy
`
`U.S. DISTRICT COURT
`for the Southern District of New York
`DEFENDANT
`Genevant Sciences GmbH and Arbutus Biopharma Corp.
`
`PLAINTIFF
`Acuitas Therapeutics Inc.
`
`|Formatmid/yyyy_||Formatmid/yyyy_|
`
`In the above—entitled case, the following patent(s)/ trademark(s) have been included:
`INCLUDED BY
`
`G
`CJ CrossBill
`
`G
`LC] Other Pleading
`
`ee
`
`
`m/diyyyy_|
`
`
`aa
`
`G
`CL] Amendment
`
`G
`LC] Answer
`
`Format|Format
`In the above—entitled case, the following decision has been rendered or judgementissued:
`DECISION/JUDGEMENT
`
`Format m/d/yyyy
`Copy 1—Uponinitiation of action, mail this copy to Director Copy 3—Upontermination ofaction, mail this copy to Director
`Copy 2—Uponfiling document adding patent(s), mail this copy to Director Copy 4—Casefile copy
`
`oo a
`
`
`
`a cc [Reset|
`
`
`
`Case 1:22-cv-02229-MKV Document 5 Filed 03/18/22 Page 2 of 2
`Case 1:22-cv-02229-MKV Document5 Filed 03/18/22 Page 2 of 2
`
`ATTACHMENT A
`
`Patents
`
`Arbutus Biopharma Corp.
`
`Patent No.
`
`Date of Patent
`
`Holder of Patent
`
`9,364,435
`
`June 14, 2016
`
`